11h
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...
Tempus AI Inc. shares rose after it said it received 510 (k) clearance from the Food and Drug Administration for its RNA-based in vitro diagnostic device. Its stock recently rose 5.2% to $92.85 in ...
4hon MSN
Multi-scale analysis reveals FGFR1 inhibition as effective strategy against cardiac fibrosis
Through a comprehensive approach combining transcriptomic profiling, histological analysis, and functional validation in ...
AZoLifeSciences on MSN
Advanced Statistical Method Reduces Noise in Single-Cell RNA-Sequencing Data
The world of cells is surprisingly noisy. Each cell carries unique genetic information, but when we try to measure cellular ...
Alcohol doesn’t just damage the liver — it locks its cells in a strange “in-between” state that prevents them from healing.
The world of cells is surprisingly noisy. Each cell carries unique genetic information, but when we try to measure cellular ...
Investor's Business Daily on MSN
IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance
Tempus AITEM stock surged to a record high Monday after the Food and Drug Administration cleared its new device to help ...
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in pediatric neurology through three poster presentations and a ...
Researchers at the Max Planck Institute for Brain Research have mapped the molecular landscape of the mouse hippocampus, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback